Literature DB >> 33776782

Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles.

Yao Lu1,2, Yichao Niu1,2, Yuan Wang1,2, Yaqiong He1,2, Ying Ding1,2, Xinyuan Lu3, Bing Xu1,2, Steven R Lindheim4, Yun Sun1,2.   

Abstract

OBJECTIVE: Concern regarding the adverse impact of pretreatment of oral contraceptives (OC) prior to ovarian stimulation for in vitro fertilization (IVF) on pregnancy outcome has been debated. We investigated factors that may be associated with live birth rate (LBR) in fresh embryo transfer cycles after OC pretreatment.
METHODS: A retrospective study was conducted at the Reproductive Center of Ren Ji Hospital, Shanghai, China. 814 women aged 20-35 years undergoing their first autologous IVF cycle and fresh embryo transfer after OC pretreatment were included. Long gonadotropin releasing hormone (GnRH) agonist (a) or GnRH antagonist (ant) protocol was used for ovarian stimulation. Predictive factors for LBR were identified using multivariate logistic regression analysis.
RESULTS: Multivariate logistic regression analysis demonstrated that using GnRH-ant protocol for ovarian stimulation was associated with significantly lower LBR (OR 0.70, 95% CI 0.52-0.93), while endometrial thickness on day of hCG trigger was associated with increased LBR (OR 1.16, 95% CI 1.06-1.27). Despite comparable patients' age, duration of infertility, BMI and basal FSH between GnRH-a and GnRH-ant groups, those using GnRH-ant resulted in significantly lower LBR compared to the GnRH-a group (37.4 vs. 48.5%, p = 0.002). Using ROC analysis and a cut-off endometrial thickness of < and ≥ 9.5 mm, those < 9.5 mm using GnRH-ant resulted in significantly lower LBR (28.5 vs. 43.4%, p = 0.004), while no differences were noted with an endometrial thickness ≥9.5 mm (49.6 vs. 51.1%, p = 0.78).
CONCLUSIONS: Live birth was significantly impacted in OC pre-treated GnRH-ant cycles with an endometrial thickness of <9.5 mm on day of hCG trigger. Cryopreservation of all embryos in these cycles should be considered.
Copyright © 2021 Lu, Niu, Wang, He, Ding, Lu, Xu, Lindheim and Sun.

Entities:  

Keywords:  GnRH agonist; GnRH antagonist; fresh embryo transfer; in vitro fertilization; oral contraceptive

Year:  2021        PMID: 33776782      PMCID: PMC7991902          DOI: 10.3389/fphys.2021.576917

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  21 in total

1.  Insights into semen analysis: a Chinese perspective on the fifth edition of the WHO laboratory manual for the examination and processing of human semen.

Authors:  Wen-Hong Lu; Yi-Qun Gu
Journal:  Asian J Androl       Date:  2010-06-14       Impact factor: 3.285

2.  Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles.

Authors:  Kemal Ozgur; Murat Berkkanoglu; Hasan Bulut; Peter Humaidan; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2015-12-23       Impact factor: 3.412

3.  Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.

Authors:  Chung-Hoon Kim; Gyun-Ho Jeon; Yong-Pil Cheon; Ilkyung Jeon; Sung-Hoon Kim; Hee-Dong Chae; Byung-Moon Kang
Journal:  Fertil Steril       Date:  2009-06-12       Impact factor: 7.329

4.  The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles.

Authors:  Pedro Montoya-Botero; Francisca Martinez; Jorge Rodríguez-Purata; Ignacio Rodríguez; Buenaventura Coroleu; Nikolaos P Polyzos
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

5.  Effects of oral contraceptive pretreatment on IVF outcomes in women following a GnRH agonist protocol.

Authors:  Lan Xu; Lingling Ding; Jingjing Jiang; Peihao Liu; Daimin Wei; Yingying Qin
Journal:  Reprod Biomed Online       Date:  2019-08-16       Impact factor: 3.828

6.  Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles.

Authors:  Xi Yuan; Sotirios H Saravelos; Qiong Wang; Yanwen Xu; Tin-Chiu Li; Canquan Zhou
Journal:  Reprod Biomed Online       Date:  2016-05-13       Impact factor: 3.828

Review 7.  To pill or not to pill in GnRH antagonist cycles: that is the question!

Authors:  Juan A Garcia-Velasco; Human M Fatemi
Journal:  Reprod Biomed Online       Date:  2014-10-05       Impact factor: 3.828

Review 8.  Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.

Authors:  Cindy Farquhar; Luk Rombauts; Jan Am Kremer; Anne Lethaby; Reuben Olugbenga Ayeleke
Journal:  Cochrane Database Syst Rev       Date:  2017-05-25

9.  Effect of pretreatment oral contraceptives on fresh and cumulative live birth in vitro fertilization outcomes in ovulatory women.

Authors:  Yao Lu; Yuan Wang; Ting Zhang; Guiquan Wang; Yaqiong He; Steven R Lindheim; Zhangsheng Yu; Yun Sun
Journal:  Fertil Steril       Date:  2020-07-31       Impact factor: 7.329

10.  Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization.

Authors:  Martin D Keltz; Puja S Gera; Josh Skorupski; Daniel E Stein
Journal:  Fertil Steril       Date:  2007-08       Impact factor: 7.329

View more
  3 in total

1.  Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT.

Authors:  Renyuan Li; Tingting Mai; Siyuan Zheng; Ying Zhang
Journal:  Arch Gynecol Obstet       Date:  2022-07-13       Impact factor: 2.493

2.  GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression.

Authors:  Ding-Fei Xu; Pei-Pei Liu; Lu Fan; Qi Xie; Zhi-Qin Zhang; Li-Qun Wang; Qiong-Fang Wu; Jun Tan
Journal:  Reprod Biol Endocrinol       Date:  2022-02-04       Impact factor: 5.211

3.  Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study.

Authors:  Ying Ding; Yihong Jiang; Mingjiang Zhu; Qinling Zhu; Yaqiong He; Yao Lu; Yuan Wang; Jia Qi; Yifan Feng; Rong Huang; Huiyong Yin; Shengxian Li; Yun Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.